Works matching AU Hong, David S.

Results: 131
    1

    First‐in‐human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumors.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 13, p. 1, doi. 10.1002/cncr.35939
    By:
    • Yap, Timothy A.;
    • Rixe, Olivier;
    • Baldini, Capucine;
    • Brown‐Glaberman, Ursa;
    • Efuni, Sergey;
    • Hong, David S.;
    • Massard, Christophe;
    • Muzaffar, Jameel;
    • Varga, Andreea;
    • Yilmaz, Emrullah;
    • Ikawa, Yuta;
    • Shiue, Lisa H.;
    • Liu, Yi;
    • Hruska, Matthew W.;
    • Zhao, Henry;
    • Tokunaga, Akihiro;
    • Sahebjam, Solmaz
    Publication type:
    Article
    2

    Post-Discharge Survival Outcomes of Patients with Advanced Cancer from the University of Texas MD Anderson Cancer Center Investigational Cancer Therapeutics (Phase I Trials) Inpatient Unit.

    Published in:
    Oncology, 2017, v. 92, n. 1, p. 14, doi. 10.1159/000449505
    By:
    • Kinahan, Holly;
    • Maiti, abhishek;
    • Hess, Kenneth;
    • Dempsey, Jennifer;
    • Beatty, Laura;
    • Baldwin, Sarah;
    • Hong, David S.;
    • Naing, aung;
    • Fu, Siqing;
    • Tsimberidou, apostolia M.;
    • Piha-Paul, Sarina;
    • Janku, Filip;
    • Karp, Daniel;
    • Reddy, Suresh;
    • Yennu, Sriram;
    • Epner, Daniel;
    • Bruera, Eduardo;
    • Meric-Bernstam, Funda;
    • Falchook, Gerald;
    • Subbiah, Vivek
    Publication type:
    Article
    3
    4

    Larotrectinib Treatment for Patients With TRK Fusion-Positive Salivary Gland Cancers.

    Published in:
    Oncologist, 2024, v. 29, n. 6, p. e779, doi. 10.1093/oncolo/oyac080
    By:
    • Le, Xiuning;
    • Baik, Christina;
    • Bauman, Jessica;
    • Gilbert, Jill;
    • Brose, Marcia S;
    • Grilley-Olson, Juneko E;
    • Patil, Tejas;
    • McDermott, Ray;
    • Raez, Luis E;
    • Johnson, Jennifer M;
    • Shen, Lin;
    • Tahara, Makoto;
    • Ho, Alan L;
    • Norenberg, Ricarda;
    • Dima, Laura;
    • Brega, Nicoletta;
    • Drilon, Alexander;
    • Hong, David S
    Publication type:
    Article
    5

    First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.

    Published in:
    Oncologist, 2024, v. 29, n. 4, p. e514, doi. 10.1093/oncolo/oyad338
    By:
    • Piha-Paul, Sarina A;
    • Xu, Binghe;
    • Dumbrava, Ecaterina E;
    • Fu, Siqing;
    • Karp, Daniel D;
    • Meric-Bernstam, Funda;
    • Hong, David S;
    • Rodon, Jordi A;
    • Tsimberidou, Apostolia M;
    • Raghav, Kanwal;
    • Ajani, Jaffer A;
    • Conley, Anthony P;
    • Mott, Frank;
    • Fan, Ying;
    • Fan, Jean;
    • Peng, Peng;
    • Wang, Hui;
    • Ni, Shumao;
    • Sun, Caixia;
    • Qiang, Xiaoyan
    Publication type:
    Article
    6

    Overview of Ocular Side Effects of Selinexor.

    Published in:
    Oncologist, 2021, v. 26, n. 7, p. 619, doi. 10.1002/onco.13756
    By:
    • Al‐Zubidi, Nagham;
    • Gombos, Dan S.;
    • Hong, David S.;
    • Subbiah, Vivek;
    • Fu, Siqing;
    • Ahnert, Jordi Rodon;
    • Piha‐Paul, Sarina A.;
    • Tsimberidou, Apostolia M.;
    • Karp, Daniel D.;
    • Bernstam, Funda Meric;
    • Naing, Aung
    Publication type:
    Article
    7
    8

    Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study.

    Published in:
    2019
    By:
    • George, Goldy C;
    • Iwuanyanwu, Eucharia C;
    • Buford, Adrianna S;
    • Piha-Paul, Sarina A;
    • Subbiah, Vivek;
    • Fu, Siqing;
    • Karp, Daniel D;
    • Pant, Shubham;
    • Hinojosa, Christina O;
    • Hess, Kenneth R;
    • Cleeland, Charles S;
    • Bernstam, Elmer V;
    • Meric-Bernstam, Funda;
    • Hong, David S
    Publication type:
    journal article
    9

    Research Priorities of Individuals and Families With Sex Chromosome Aneuploidies.

    Published in:
    American Journal of Medical Genetics. Part A, 2025, v. 197, n. 6, p. 1, doi. 10.1002/ajmg.a.63998
    By:
    • Carl, Alexandra;
    • Bothwell, Samantha;
    • Farah, Fathia;
    • Swenson, Karli;
    • Hong, David;
    • Prakash, Siddharth;
    • Strang, John;
    • Tartaglia, Nicole;
    • Raznahan, Armin;
    • Ross, Judith;
    • Rogol, Alan D.;
    • Dawczyk, Anna;
    • Hong, David S.;
    • Decker, Gail;
    • Cover, Ginnie;
    • Cohen, Lilian L.;
    • Davis, Shanlee;
    • Gerken, Steve;
    • Howell, Susan;
    • Bamba, Vaneeta
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    The Prevalence and Impact of Hyperglycemia and Hyperlipidemia in Patients With Advanced Cancer Receiving Combination Treatment With the Mammalian Target of Rapamycin Inhibitor Temsirolimus and Insulin Growth Factor-Receptor Antibody Cixutumumab.

    Published in:
    Oncologist, 2015, v. 20, n. 7, p. 737, doi. 10.1634/theoncologist.2015-0065
    By:
    • Busaidy, Naifa L.;
    • LoRusso, Patricia;
    • Lawhorn, Kristie;
    • Hess, Kenneth R.;
    • Habra, Mohammed Amir;
    • Fu, Siqing;
    • Hong, David S.;
    • Chen, Helen X.;
    • Doyle, Lawrence A.;
    • Kurzrock, Razelle;
    • Naing, Aung
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.

    Published in:
    2016
    By:
    • Bilen, Mehmet;
    • Patel, Amy;
    • Hess, Kenneth;
    • Munoz, Javier;
    • Busaidy, Naifa;
    • Wheler, Jennifer;
    • Janku, Filip;
    • Falchook, Gerald;
    • Hong, David;
    • Meric-Bernstam, Funda;
    • Habra, Mouhammed;
    • Naing, Aung;
    • Bilen, Mehmet Asim;
    • Hess, Kenneth R;
    • Busaidy, Naifa L;
    • Wheler, Jennifer J;
    • Falchook, Gerald S;
    • Hong, David S;
    • Habra, Mouhammed Amir
    Publication type:
    journal article
    28
    29
    30
    31
    32
    33

    Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkz093
    By:
    • Piha-Paul, Sarina A;
    • Hann, Christine L;
    • French, Christopher A;
    • Cousin, Sophie;
    • Braña, Irene;
    • Cassier, Phillippe A;
    • Moreno, Victor;
    • Bono, Johann S de;
    • Harward, Sara Duckworth;
    • Ferron-Brady, Geraldine;
    • Barbash, Olena;
    • Wyce, Anastasia;
    • Wu, Yuehui;
    • Horner, Thierry;
    • Annan, Meg;
    • Parr, Nigel J;
    • Prinjha, Rabinder K;
    • Carpenter, Christopher L;
    • Hilton, John;
    • Hong, David S
    Publication type:
    Article
    34

    Patient-reported symptom burden in patients with rare cancers receiving pembrolizumab in a phase II Clinical Trial.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-16588-3
    By:
    • Mendoza, Tito R.;
    • Hong, David S.;
    • Peterson, Christine B.;
    • Stephen, Bettzy;
    • Dumbrava, Ecaterina;
    • Pant, Shubbam;
    • Tsimberidou, Apostolia Maria;
    • Yap, Timothy Anthony;
    • Sheshadri, Ajay;
    • Altan, Mehmet;
    • George, Goldy;
    • Castillo, Lilibeth;
    • Rodriguez, Enedelia;
    • Gong, Jing;
    • Subbiah, Vivek;
    • Janku, Filip;
    • Fu, Siqing;
    • Piha-Paul, Sarina A.;
    • Ahnert, Jordi Rodon;
    • Karp, Daniel D.
    Publication type:
    Article
    35
    36
    37

    Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 23, p. 3772, doi. 10.1002/cncr.35036
    By:
    • Kummar, Shivaani;
    • Shen, Lin;
    • Hong, David S.;
    • McDermott, Ray;
    • Keedy, Vicki L.;
    • Casanova, Michela;
    • Demetri, George D.;
    • Dowlati, Afshin;
    • Melcón, Soledad Gallego;
    • Lassen, Ulrik N.;
    • Leyvraz, Serge;
    • Liu, Tianshu;
    • Moreno, Victor;
    • Patel, Jyoti;
    • Patil, Tejas;
    • Mallick, Atrayee Basu;
    • Sousa, Nuno;
    • Tahara, Makoto;
    • Ziegler, David S.;
    • Norenberg, Ricarda
    Publication type:
    Article
    38

    Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 14, p. 2201, doi. 10.1002/cncr.34773
    By:
    • Nelson, Blessie Elizabeth;
    • Saleem, Sadia;
    • Damodaran, Senthil;
    • Somaiah, Neeta;
    • Piha‐Paul, Sarina;
    • Moore, Julia Ann;
    • Yilmaz, Bulent;
    • Ogbonna, Deby;
    • Karp, Daniel D.;
    • Dumbrava, Ecaterina;
    • Tsimberidou, Apostolia M.;
    • Hong, David S.;
    • Rodon Ahnert, Jordi;
    • Milton, Denái R.;
    • Zheng, Xiaofeng;
    • Booser, Daniel J.;
    • Ibrahim, Nuhad K.;
    • Conley, Anthony P.;
    • Bhosale, Priya;
    • Rojas Hernandez, Cristhiam M.
    Publication type:
    Article
    39

    Challenges and opportunities associated with the MD Anderson IMPACT2 randomized study in precision oncology.

    Published in:
    NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00317-0
    By:
    • Vo, Henry Hiep;
    • Fu, Siqing;
    • Hong, David S.;
    • Karp, Daniel D.;
    • Piha-Paul, Sarina;
    • Subbiah, Vivek;
    • Janku, Filip;
    • Naing, Aung;
    • Yap, Timothy A.;
    • Rodon, Jordi;
    • Ajani, Jaffer A.;
    • Cartwright, Carrie;
    • Johnson, Amber;
    • Song, I-Wen;
    • Beck, Jennifer;
    • Kahle, Michael;
    • Nogueras-Gonzalez, Graciela M.;
    • Miller, Vincent;
    • Chao, Calvin;
    • Vining, David J.
    Publication type:
    Article
    40

    A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00214-y
    By:
    • Mansfield, Aaron S.;
    • Hong, David S.;
    • Hann, Christine L.;
    • Farago, Anna F.;
    • Beltran, Himisha;
    • Waqar, Saiama N.;
    • Hendifar, Andrew E.;
    • Anthony, Lowell B.;
    • Taylor, Matthew H.;
    • Bryce, Alan H.;
    • Tagawa, Scott T.;
    • Lewis, Karl;
    • Niu, Jiaxin;
    • Chung, Christine H.;
    • Cleary, James M.;
    • Rossi, Michael;
    • Ludwig, Carrianne;
    • Valenzuela, Ricardo;
    • Luo, Yan;
    • Aggarwal, Rahul
    Publication type:
    Article
    41

    Precision medicine: preliminary results from the Initiative for Molecular Profiling and Advanced Cancer Therapy 2 (IMPACT2) study.

    Published in:
    NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00159-2
    By:
    • Tsimberidou, Apostolia Maria;
    • Hong, David S.;
    • Fu, Siqing;
    • Karp, Daniel D.;
    • Piha-Paul, Sarina;
    • Kies, Merrill S.;
    • Ravi, Vinod;
    • Subbiah, Vivek;
    • Patel, Sunil M.;
    • Tu, Shi-Ming;
    • Janku, Filip;
    • Heymach, John;
    • Johnson, Amber;
    • Cartwright, Carrie;
    • Zhao, Li;
    • Zhang, Jianhua;
    • Berry, Donald A.;
    • Vining, David J.;
    • Futreal, Andrew;
    • Miller, Vincent A.
    Publication type:
    Article
    42
    43

    Deep Learning–Assisted Diagnosis of Cerebral Aneurysms Using the HeadXNet Model.

    Published in:
    JAMA Network Open, 2019, v. 2, n. 6, p. e195600, doi. 10.1001/jamanetworkopen.2019.5600
    By:
    • Park, Allison;
    • Chute, Chris;
    • Rajpurkar, Pranav;
    • Lou, Joe;
    • Ball, Robyn L.;
    • Shpanskaya, Katie;
    • Jabarkheel, Rashad;
    • Kim, Lily H.;
    • McKenna, Emily;
    • Tseng, Joe;
    • Ni, Jason;
    • Wishah, Fidaa;
    • Wittber, Fred;
    • Hong, David S.;
    • Wilson, Thomas J.;
    • Halabi, Safwan;
    • Basu, Sanjay;
    • Patel, Bhavik N.;
    • Lungren, Matthew P.;
    • Ng, Andrew Y.
    Publication type:
    Article
    44

    Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit.

    Published in:
    Clinical Breast Cancer, 2014, v. 14, n. 6, p. 468, doi. 10.1016/j.clbc.2014.06.001
    By:
    • Debora, de Melo Gagliato;
    • Fontes Jardim, Denis L.;
    • Falchook, Gerald;
    • Tang, Chad;
    • Zinner, Ralph;
    • Wheler, Jennifer J.;
    • Janku, Filip;
    • Subbiah, Vivek;
    • Piha-Paul, Sarina A.;
    • Fu, Siqing;
    • Hess, Kenneth;
    • Roy-Chowdhuri, Sinchita;
    • Moulder, Stacy;
    • Gonzalez-Angulo, Ana M.;
    • Meric-Bernstam, Funda;
    • Hong, David S.
    Publication type:
    Article
    45

    Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling.

    Published in:
    eLife, 2021, p. 1, doi. 10.7554/eLife.70130
    By:
    • Butner, Joseph D.;
    • Martin, Geoffrey V.;
    • Zhihui Wang;
    • Corradetti, Bruna;
    • Ferrari, Mauro;
    • Esnaola, Nestor;
    • Chung, Caroline;
    • Hong, David S.;
    • Welsh, James W.;
    • Hasegawa, Naomi;
    • Mittendorf, Elizabeth A.;
    • Curley, Steven A.;
    • Shu-Hsia Chen;
    • Ping-Ying Pan;
    • Libutti, Steven K.;
    • Ganesan, Shridar;
    • Sidman, Richard L.;
    • Pasqualini, Renata;
    • Arap, Wadih;
    • Koay, Eugene J.
    Publication type:
    Article
    46
    47

    Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 6, p. 997, doi. 10.1093/neuonc/noab274
    By:
    • Doz, François;
    • Tilburg, Cornelis M van;
    • Geoerger, Birgit;
    • Højgaard, Martin;
    • Øra, Ingrid;
    • Boni, Valentina;
    • Capra, Michael;
    • Chisholm, Julia;
    • Chung, Hyun Cheol;
    • DuBois, Steven G;
    • Gallego-Melcon, Soledad;
    • Gerber, Nicolas U;
    • Goto, Hiroaki;
    • Grilley-Olson, Juneko E;
    • Hansford, Jordan R;
    • Hong, David S;
    • Italiano, Antoine;
    • Kang, Hyoung Jin;
    • Nysom, Karsten;
    • Thorwarth, Anne
    Publication type:
    Article
    48

    A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.

    Published in:
    OncoImmunology, 2024, v. 13, n. 1, p. 1, doi. 10.1080/2162402X.2023.2290787
    By:
    • Lin, Chia-Chi;
    • Garralda, Elena;
    • Schöffski, Patrick;
    • Hong, David S.;
    • Siu, Lillian L.;
    • Martin, Miguel;
    • Maur, Michela;
    • Hui, Rina;
    • Soo, Ross A;
    • Chiu, Joanne;
    • Zhang, Tian;
    • Ma, Brigette;
    • Kyi, Chrisann;
    • Tan, Daniel SW;
    • Cassier, Philippe A.;
    • Sarantopoulos, John;
    • Weickhardt, Andrew;
    • Carvajal, Richard D.;
    • Spratlin, Jennifer;
    • Esaki, Taito
    Publication type:
    Article
    49
    50